Local Anesthetic Systemic Toxicity (LAST)
Maximum Dosing Limits
For adults, administer no more than 4.5 mg/kg of lidocaine without epinephrine and 7.0 mg/kg of lidocaine with epinephrine in a single treatment 1. For children, these limits are significantly lower: 1.5-2.0 mg/kg without epinephrine and 3.0-4.5 mg/kg with epinephrine 1. In multistage procedures like Mohs surgery, a maximum of 500 mg lidocaine (50 mL of 1% solution) delivered over several hours is recommended 1.
When combining multiple amide local anesthetics (lidocaine, articaine, bupivacaine), use the fractional dose rule to calculate cumulative toxicity risk 2. This means if you use 50% of the maximum dose of one agent, you can only use 50% of the maximum dose of another agent. The additive systemic toxicity of combined agents is frequently underappreciated and represents a significant clinical pitfall 2.
Critical Patient Factors That Lower Toxic Threshold:
- Extremes of age (infants and elderly)
- Hepatic dysfunction
- Low cardiac output states
- Pregnancy
- Metabolic diseases 3, 4
Early Signs and Recognition
Neurologic symptoms typically precede cardiovascular collapse 5, 4. The progression follows a predictable pattern:
Initial CNS Manifestations:
- Perioral numbness or tingling
- Metallic taste
- Tinnitus
- Agitation or confusion
- Slurred speech
- Muscle twitching
- Seizures (most common presenting sign) 5
Cardiovascular Manifestations:
- Initial: Hypertension, tachycardia, premature ventricular contractions 4
- Progressive: Bradycardia, conduction disturbances, arrhythmias
- Severe: Circulatory collapse, asystole 4, 6
A critical caveat: onset of toxicity is increasingly delayed with modern ultrasound-guided techniques 3. Large-volume depot injections of dilute local anesthetic can take hours to reach peak plasma levels 5. This delayed presentation makes diagnosis challenging and requires extended vigilance.
Prevention Measures
The four essential prevention steps are: use the lowest effective dose, aspirate before each injection, use incremental injections, and continuously communicate with the patient to monitor for early toxicity 1.
Specific Risk Mitigation Strategies:
- Use ultrasound guidance - demonstrated to reduce LAST risk 3
- Perform aspiration test before each injection to avoid intravascular administration 4
- Divide doses - never inject the entire calculated dose as a single bolus 4
- Consider lower-toxicity agents - ropivacaine and levobupivacaine have better safety profiles than bupivacaine 4
- Discuss dosages during surgical "time-out" as a team safety check 5
- Thoracic blocks require extra caution - use lower doses due to proximity to the heart 7
Emergency Treatment Protocol
At the first sign of serious systemic toxicity, immediately administer 20% intravenous lipid emulsion (ILE) while simultaneously managing airway and circulation 5, 4, 6.
Immediate Actions:
- Stop local anesthetic administration immediately 4, 6
- Call for help - request assistance 4
- Secure airway and administer 100% oxygen 5, 4
- Prepare for tracheal intubation and mechanical ventilation if needed 4
Lipid Emulsion Therapy Dosing:
- Initial bolus: 100 mL for adults >70 kg 5
- Initial bolus: 1.5 mL/kg for adults <70 kg or children 5
- Continue with infusion per established protocols 5, 6
Seizure Management:
- Benzodiazepines are the recommended first-line treatment 4
- Avoid propofol in cardiovascular instability (can worsen hypotension)
Modified ACLS Considerations:
- Reduce epinephrine doses - standard ACLS doses may be harmful in LAST 6
- Avoid vasopressin, calcium channel blockers, beta-blockers, and local anesthetics 6
- Prolonged resuscitation may be necessary - lipid emulsion takes time to work 6
Essential Preparedness:
All facilities where local anesthetics are administered must have immediate access to lipid emulsion therapy, airway equipment, benzodiazepines, and resuscitation capabilities 5, 4. The incidence is 1-11 cases per 10,000 procedures 4, making preparedness mandatory despite rarity.
Differential Diagnosis Pitfall:
LAST symptoms can be obscured by or mistaken for other perioperative processes 5. Consider vasovagal syncope, anxiety/panic attacks, allergic reactions, and other causes of altered mental status or cardiovascular instability. The key distinguishing feature is the temporal relationship to local anesthetic administration and the characteristic progression from CNS to cardiovascular symptoms.